Senolytics: A Novel Strategy for Neuroprotection in ALS?
Amyotrophic lateral sclerosis (ALS) is a progressive motor neurodegenerative disease that currently has no cure and has few effective treatments. On a cellular level, ALS manifests through significant changes in the proper function of astrocytes, microglia, motor neurons, and other central nervous s...
Guardado en:
Autores principales: | Alexandra Maximova, Eryn L. Werry, Michael Kassiou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/337823380b344cbeb83fcaaed13ab187 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amyotrophic lateral sclerosis official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
Publicado: (2006) -
Enhancement of Bone-Forming Ability on Beta-Tricalcium Phosphate by Modulating Cellular Senescence Mechanisms Using Senolytics
por: Xinchen Wang, et al.
Publicado: (2021) -
Amyotrophic lateral sclerosis and frontotemporal degeneration
Publicado: (2000) -
Regulation of Endoplasmic Reticulum–Mitochondria Tethering and Ca<sup>2+</sup> Fluxes by TDP-43 via GSK3β
por: Caterina Peggion, et al.
Publicado: (2021) -
Biomolecular Evaluation of Piceatannol’s Effects in Counteracting the Senescence of Mesenchymal Stromal Cells: A New Candidate for Senotherapeutics?
por: Nicola Alessio, et al.
Publicado: (2021)